However, in tumour-derived MSCs, only CCN2 inhibited cancer cell proliferation, mobility and invasion, and it decreased the levels of MMP-9, MMP-2 and epithelial-mesenchymal transition markers in vitro. The gene discussed is MMP9; the disease is neoplasm.